Clinical Trial Update: Efficacy and Safety of SPD503 in Combination With Psychostimulants [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating SPD503 in combination with psychostimulants for ADHD has completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• SPD503

Snippet

Sponsor: Shire | Conditions: ADHD | Phase 3 | Status: COMPLETED | Results posted: 2010-11-23